Skip to content
value.today

Amphora Medical, Inc.

Total raised
$24 M
2 rounds on record
Latest round
$11 M
Jul 2017
First round on record
May 2013
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Amphora Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2017$11 MNo. 2$10 to $50 million

Amphora Medical, Inc.: Raise no. 2, Jul 2017

Investors in this round

12 investors had bought by the notice of Jul 27, 2017: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $36 M offered; $25 M still to sell
Smallest investment taken
$5,099
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$700,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Thomas V. Ressemann · Executive Officer, Director
  • Chris J. Owens · Director
  • Ketan V. Patel · Director
  • Marc J. Galletti · Director
  • Nicole J. Walker · Director
  • Thomas J. Thaler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Aquilo Partners, L.P. (CRD 114909) · San Francisco, CaliforniaSold in CA, MA

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, manager or promoter will receive any payments from the proceeds of this offering.”

Signed by Thomas V. Ressemann, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 27, 2017. Read the notice at the SEC.

equitySEC
May 2013$13 MNo. 1$10 to $50 million

Amphora Medical, Inc.: Raise no. 1, May 2013

Investors in this round

8 investors had bought by the notice of Jul 15, 2015: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$768,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Tom Ressemann · Executive Officer, Director
  • Dan Sachs · Director
  • Michael Liang · Director
  • Robert Weisskoff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “A portion of the proceeds will be used to pay the salaries of the executive officers in the ordinary course of business.”

Signed by Tom Ressemann, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 15, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Amphora Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2017).

    SEC Form D · Jul 2017

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2017

That is all the official record says: Amphora Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Amphora Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 12 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Amphora Medical, Inc.
NameRoleNamed in
Thomas V. RessemannExecutive officerJul 2017
Tom RessemannExecutive officerJul 2015
Chris J. OwensDirectorJul 2017
Ketan V. PatelDirectorJul 2017
Marc J. GallettiDirectorJul 2017
Nicole J. WalkerDirectorJul 2017
Thomas J. ThalerDirectorJul 2017
Thomas V. RessemannDirectorJul 2017
Dan SachsDirectorJul 2015
Michael LiangDirectorJul 2015
Robert WeisskoffDirectorJul 2015
Tom RessemannDirectorJul 2015